ATP13A5 Activators are a class of compounds specifically designed to target and enhance the activity of ATP13A5, a member of the P-type ATPase family, which is known for its role in transporting ions and lipids across cellular membranes using ATP hydrolysis for energy. ATP13A5, in particular, has drawn interest due to its potential involvement in maintaining ionic homeostasis and possibly lipid transport within cells, although its precise physiological functions and substrates remain an area of ongoing research. The development of ATP13A5 Activators is motivated by the hypothesis that modulating this protein's activity could have significant implications for cellular processes dependent on ion gradients and membrane lipid composition. These activators are synthesized through intricate chemical processes, aiming to produce molecules that can interact with ATP13A5 to enhance its ATPase activity, thereby potentially influencing its transport capabilities. The design of these compounds requires a deep understanding of ATP13A5's structure, including its ATP-binding domains and transmembrane regions, to identify sites where activators can bind and modulate the enzyme's activity effectively.
The exploration of ATP13A5 Activators involves a comprehensive approach, integrating methodologies from enzymology, structural biology, and membrane biophysics. Researchers employ a range of techniques to investigate the interaction between these activators and ATP13A5, including ATPase activity assays to measure the enzyme's activity in the presence of potential activators and membrane-based assays to assess changes in ion or lipid transport. Structural studies, such as X-ray crystallography or cryo-electron microscopy, are crucial for elucidating the three-dimensional architecture of ATP13A5, revealing how activators may bind and induce conformational changes that enhance the protein's function. Computational modeling and simulation studies complement these experimental approaches, offering predictions about the interaction dynamics between ATP13A5 and activator molecules, guiding the optimization of compound design for increased specificity and potency. Through this multidisciplinary research effort, the study of ATP13A5 Activators aims to shed light on the regulatory mechanisms of P-type ATPases like ATP13A5, contributing to a deeper understanding of their role in cellular physiology and the potential for modulating these processes through targeted chemical intervention.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels and potentially activating PKA, which can phosphorylate and regulate ATPases. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases 1 and 2A, potentially preventing dephosphorylation and maintaining ATPases in an active state. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that increases intracellular calcium concentration, potentially modulating calcium-dependent ATPases. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi structure and function, which may affect the localization and activity of certain ATPases. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Sodium ionophore that alters intracellular ion concentrations and could indirectly influence sodium/potassium ATPases. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Known inhibitor of the Na+/K+ ATPase but at low concentrations, may exert complex regulatory effects on other ATPases. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), affecting calcium homeostasis and potentially influencing related ATPases. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular Ca2+ and could modulate Ca2+-dependent ATPases. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, which could affect the maturation and function of glycoprotein ATPases. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Inhibitor of SERCA, leading to increased cytosolic Ca2+ which may indirectly modulate other Ca2+-regulated ATPases. | ||||||